Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118549872 | 11854987 | 2 | F | 20000331 | 20160826 | 20151221 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-11544392 | BRISTOL MYERS SQUIBB | 0.00 | DY | F | Y | 2.90000 | KG | 20160826 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118549872 | 11854987 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | 40 MG, BID | U | 20412 | 40 | MG | CAPSULE, HARD | BID | |||||
| 118549872 | 11854987 | 2 | SS | ZERIT | STAVUDINE | 1 | Oral | 1 MG/ML | Y | 0 | 3 | MG | ORAL SOLUTION | BID | |||||
| 118549872 | 11854987 | 3 | SS | CRIXIVAN | INDINAVIR SULFATE | 1 | Transplacental | 400 MG, UNK | U | 0 | 400 | MG | |||||||
| 118549872 | 11854987 | 4 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | 150 MG, BID | U | 0 | 150 | MG | BID | ||||||
| 118549872 | 11854987 | 5 | SS | VIRAMUNE | NEVIRAPINE | 1 | Oral | 6 MG, ONE TIME DOSE | Y | 0 | 6 | MG | |||||||
| 118549872 | 11854987 | 6 | SS | VIRAMUNE | NEVIRAPINE | 1 | Transplacental | 200 MG, UNK | U | 0 | 200 | MG | |||||||
| 118549872 | 11854987 | 7 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | 200 MG, ONE TIME DOSE | U | 0 | 200 | MG | |||||||
| 118549872 | 11854987 | 8 | SS | SPASFON | PHLOROGLUCINOL | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118549872 | 11854987 | 9 | SS | SALBUTAMOL | ALBUTEROL | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118549872 | 11854987 | 1 | Product used for unknown indication |
| 118549872 | 11854987 | 2 | Prophylaxis |
| 118549872 | 11854987 | 3 | Product used for unknown indication |
| 118549872 | 11854987 | 4 | Product used for unknown indication |
| 118549872 | 11854987 | 5 | Prophylaxis |
| 118549872 | 11854987 | 6 | Product used for unknown indication |
| 118549872 | 11854987 | 7 | Product used for unknown indication |
| 118549872 | 11854987 | 8 | Product used for unknown indication |
| 118549872 | 11854987 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118549872 | 11854987 | OT |
| 118549872 | 11854987 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118549872 | 11854987 | Anaemia | |
| 118549872 | 11854987 | Blood pyruvic acid decreased | |
| 118549872 | 11854987 | Foetal exposure during pregnancy | |
| 118549872 | 11854987 | Neutropenia | |
| 118549872 | 11854987 | Skin depigmentation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118549872 | 11854987 | 1 | 20000331 | 0 | ||
| 118549872 | 11854987 | 2 | 20000331 | 20000512 | 0 | |
| 118549872 | 11854987 | 3 | 20000331 | 0 | ||
| 118549872 | 11854987 | 4 | 20000331 | 0 | ||
| 118549872 | 11854987 | 5 | 20000402 | 20000402 | 0 | |
| 118549872 | 11854987 | 6 | 20000331 | 20000331 | 0 | |
| 118549872 | 11854987 | 7 | 20000331 | 20000331 | 0 |